Related Experiment Video
Updated: Aug 16, 2026
06:39
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Aspirin and coronary heart disease: findings of a prospective study
British Medical Journal
|May 3, 1975
Insights
Regular aspirin use did not lower coronary heart disease death rates in a large study. This research suggests frequent aspirin intake offers no protection against heart disease mortality.
Area of Science:
- Cardiovascular Medicine
- Epidemiology
- Pharmacology
Background:
- Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
- Aspirin is widely used for its antiplatelet effects, with potential benefits in cardiovascular disease prevention.
- Understanding the long-term impact of regular aspirin use on CHD mortality is crucial for public health guidelines.
Purpose of the Study:
- To investigate the association between frequent aspirin consumption and coronary heart disease (CHD) mortality.
- To determine if regular aspirin use provides a protective effect against fatal CHD events.
Main Methods:
- A large-scale, prospective study involving over 1,000,000 participants.
- Participants completed a confidential questionnaire on aspirin usage frequency (never, seldom, often).
- Follow-up tracing for up to six years to record mortality data, specifically for CHD.
Main Results:
- Analysis revealed no significant difference in coronary heart disease death rates between individuals who frequently took aspirin and those who did not.
- The data indicates that often taking aspirin did not correlate with a reduced risk of dying from CHD.
Conclusions:
- Frequent aspirin consumption, as assessed in this study, does not appear to reduce the risk of death from coronary heart disease.
- These findings suggest that the widespread use of aspirin for primary prevention of CHD mortality may not be supported by this evidence.
Abstract:
Over 1 000 000 men and women answered a confidential questionnaire and were traced for up to six years afterwards. Among other questions each person was asked how often he or she took aspirin-"never", "seldom," or "often." Coronary heart disease death rates were no lower among people who took aspirin often than among those who did not do so.
Related Concept Videos
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...